Citation

85 FR 6201

Canonical document for this Federal Register citation.

Promotional Labeling and Advertising Considerations for Prescription Biological Reference and Biosimilar Products-Questions and Answers; Draft Guidance for Industry; Availability Tuesday, February 4, 2020 85 FR 6201